These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34129379)

  • 41. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2022 May; 38(4):269-270. PubMed ID: 35394346
    [No Abstract]   [Full Text] [Related]  

  • 42. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2022 Jun; 38(5):327-328. PubMed ID: 35537482
    [No Abstract]   [Full Text] [Related]  

  • 43. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2022 Apr; 38(3):201-202. PubMed ID: 35325572
    [No Abstract]   [Full Text] [Related]  

  • 44. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2023; 39(1):1-2. PubMed ID: 36579953
    [No Abstract]   [Full Text] [Related]  

  • 45. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2022 Oct; 38(8):527-528. PubMed ID: 36178951
    [No Abstract]   [Full Text] [Related]  

  • 46. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2022 Sep; 38(7):469-470. PubMed ID: 35925754
    [No Abstract]   [Full Text] [Related]  

  • 47. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2022 Nov; 38(9):592-593. PubMed ID: 36255452
    [No Abstract]   [Full Text] [Related]  

  • 48. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2024 Jun; 40(5):259-260. PubMed ID: 38597927
    [No Abstract]   [Full Text] [Related]  

  • 49. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2013; 29(6):513-4. PubMed ID: 23841863
    [No Abstract]   [Full Text] [Related]  

  • 50. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2014 Oct; 30(8):603-4. PubMed ID: 25280174
    [No Abstract]   [Full Text] [Related]  

  • 51. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2015 Sep; 31(7):363-4. PubMed ID: 26262823
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug delivery to the eye: current trends and future perspectives.
    Behar-Cohen F
    Ther Deliv; 2012 Oct; 3(10):1135-7. PubMed ID: 23116006
    [No Abstract]   [Full Text] [Related]  

  • 53. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2019; 35(1):1-2. PubMed ID: 30566384
    [No Abstract]   [Full Text] [Related]  

  • 54. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2020 May; 36(4):199-200. PubMed ID: 32186947
    [No Abstract]   [Full Text] [Related]  

  • 55. On-Label and Off-Label Clinical Studies of FDA-Approved Ophthalmic Therapeutics.
    Gopal AD; Wallach JD; Shah SA; Regillo C; Ross JS
    Ophthalmology; 2021 Feb; 128(2):332-334. PubMed ID: 32682839
    [No Abstract]   [Full Text] [Related]  

  • 56. Ocular drug delivery.
    Goepferich A
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):157. PubMed ID: 26004820
    [No Abstract]   [Full Text] [Related]  

  • 57. The accelerated drug approval.
    Novack GD
    Ocul Surf; 2010 Oct; 8(4):205-7. PubMed ID: 20964983
    [No Abstract]   [Full Text] [Related]  

  • 58. A New Vision for the Eye: Unmet Ocular Drug Delivery Needs.
    Rivers HM; Ray Chaudhuri S; Shah JC; Mittal S
    Pharm Res; 2015 Sep; 32(9):2814-23. PubMed ID: 26055402
    [No Abstract]   [Full Text] [Related]  

  • 59. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2015 May; 31(4):187-8. PubMed ID: 25938926
    [No Abstract]   [Full Text] [Related]  

  • 60. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2017 May; 33(4):214-215. PubMed ID: 28326865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.